The Beat AML program produced a comprehensive dataset on acute myeloid leukemia (AML) that included genomic data (i.e., whole-exome sequencing and RNA sequencing), ex vivo drug response, and clinical data. We have included only the drug response data from this program in this package.
beatAML
A tibble with three variables:
inhibitor
names of inhibitors
patient_id
anonymous patient ID
median
the median of drug response at corresponding inhibitor
and patient_id